I I van Gameren
Overview
Explore the profile of I I van Gameren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Gameren I, Bijzet J, Bos R, Limburg P, Vellenga E, Hazenberg B
Amyloid
. 2011 Aug;
18 Suppl 1:94-5.
PMID: 21838446
No abstract available.
2.
Bijzet J, van Gameren I, Limburg P, Bos R, Vellenga E, Hazenberg B
Amyloid
. 2011 Aug;
18 Suppl 1:71-2.
PMID: 21838437
No abstract available.
3.
Hazenberg B, van Gameren I, Bijzet J, Jager P, van Rijswijk M
Neth J Med
. 2004 Jul;
62(4):121-8.
PMID: 15255082
Amyloidosis is a group of diseases, all characterised by deposition of protein fibrils with a beta-sheet structure. This structure generates affinity of amyloid for Congo red dye and is resistant...
4.
van Gameren I, Lokhorst H, Hazenberg B, Vellenga E
Neth J Med
. 2004 Jul;
62(4):106-13.
PMID: 15255079
Systemic amyloid light chain (AL) amyloidosis is a severe disease with unfavourable prognosis. Since the late 1970s different therapeutic modalities in AL amyloidosis have been investigated, trying to prolong survival....
5.
van Gameren I, Gokemeijer J
Neth J Med
. 1998 Mar;
51(6):228-31.
PMID: 9499694
We describe a case of concurrent presentation of severe haemorrhagic cystitis and acute interstitial nephritis with eventually lethal outcome, associated with the use of tiaprofenic acid (Surgam), a propionic acid-derived...
6.
van Gameren I, Wijnja L, Louwes H, De Wolf J
J Intern Med
. 1997 Jul;
242(1):79-81.
PMID: 9260571
Pancytopenia in the course of polycythaemia vera (PV) following the proliferative and stable phase, ultimately leads to a spent phase characterized by extensive marrow fibrosis. We describe a patient with...